Cargando…
Altered glycosylation profile of purified plasma ACT from Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is one of the most frequent cause of neurodegenerative disorder in the elderly. Inflammation has been implicated in brain degenerative processes and peripheral markers of brain AD related impairment would be useful. Plasma levels of alpha-1-antichymotrypsin (ACT)...
Autores principales: | Ianni, Manuela, Manerba, Marcella, Di Stefano, Giuseppina, Porcellini, Elisa, Chiappelli, Martina, Carbone, Ilaria, Licastro, Federico |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024880/ https://www.ncbi.nlm.nih.gov/pubmed/21172065 http://dx.doi.org/10.1186/1742-4933-7-S1-S6 |
Ejemplares similares
-
Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease
por: Porcellini, Elisa, et al.
Publicado: (2013) -
Alzheimer's disease gene signature says: beware of brain viral infections
por: Porcellini, Elisa, et al.
Publicado: (2010) -
Multi factorial interactions in the pathogenesis pathway of Alzheimer’s disease: a new risk charts for prevention of dementia
por: Licastro, Federico, et al.
Publicado: (2010) -
Impaired Innate Immunity Mechanisms in the Brain of Alzheimer’s Disease
por: Romagnoli, Martina, et al.
Publicado: (2020) -
Serum neutrophil gelatinase-B associated lipocalin (NGAL) levels in Down’s syndrome patients
por: Dogliotti, Giada, et al.
Publicado: (2010)